Antibiotic prophylaxis in peripheral vascular and orthopaedic prosthetic surgery

Peripheral vascular by-pass and orthopaedic joint replacement surgery have much in common. The consequences of infection are serious and occasionally fatal. The incidence of infection varies from 0·5% to 3% depending on the anatomical site; the infecting organisms and distribution of organisms are s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of antimicrobial chemotherapy 1993, Vol.31 (suppl-B), p.65-78
1. Verfasser: STRACHAN, C
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 78
container_issue suppl-B
container_start_page 65
container_title Journal of antimicrobial chemotherapy
container_volume 31
creator STRACHAN, C
description Peripheral vascular by-pass and orthopaedic joint replacement surgery have much in common. The consequences of infection are serious and occasionally fatal. The incidence of infection varies from 0·5% to 3% depending on the anatomical site; the infecting organisms and distribution of organisms are similar. In orthopaedics a clean theatre environment, high local concentrations of anti-biotic in the cement and systemic antibiotic prophylaxis are well established methods of reducing infection rates and are supported by clinical trials. In contrast, scientific evidence supporting these three tenets is lacking for peripheral vascular surgery. There are wide variations in the choice of prophylaxis cover for peripheral vascular surgery and the first clinical cases of antibiotic containing graft material have only recently been described. The choice of an ideal antibiotic for the prophylaxis of infections associated with vascular surgery is debatable; wound and graft infections in those receiving antibiotic prophylaxis range from 0·9% to 5·8% and 0·0 to 0·9%, respectively. For both forms of surgery whether single dose, short course or longer periods of prophylaxis is preferred, it is agreed that the antibiotic must achieve adequate concentrations at the time of potential bacterial contamination. One of the limiting factors of single dose prophylaxis is the ability of the antibiotic to penetrate bone, soft tissue or haematoma. However, single dose prophylactic antibiotic cover in prosthetic surgery will attract increasing support whenever the criteria of spectrum and ‘risk period’ cover is fulfilled. This may help to contain the increase in multi-resistant bacteria, particularly staphylococci within the hospital ecosystem. Prolonged systemic administration can now be replaced by high local antibacterial activity at the site of prosthesis insertion via a bonded sealant or an impregnated cement. This permits high activity which can last for several weeks until all the lines are removed and tissue incorporation has become established.
doi_str_mv 10.1093/jac/31.suppl_B.65
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_75633965</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16886864</sourcerecordid><originalsourceid>FETCH-LOGICAL-c423t-7a01417c42ba2ffdcba56d94de3384b26c619aaeffe4f015d52d64bfece09d2c3</originalsourceid><addsrcrecordid>eNqFkU9v1DAQxS1EVZaWD8ABKQfELVs7YzvxsVSURa0ESFRCXKyJ_7Au2SS1E9T99rhstNeeRtb7vaeZZ0LeMrpmVMHFPZoLYOs0j2OnP66leEFWjEtaVlSxl2RFgYqy5gJekdcp3VNKpZDNKTltOFcNr1fk22U_hTYMUzDFGIdxu-_wMaQi9MXoYhi3LmJX_MVk5g5jgb0thjhthxGdPVjStHVP7jTH3y7uz8mJxy65N8s8I3fXn35cbcrbr5-_XF3eloZXMJU1UsZZnR8tVt5b06KQVnHrABreVtJIphCd9457yoQVlZW89c44qmxl4Ix8OOTmFR5mlya9C8m4rsPeDXPStZAASopnQSabRjaSZ5AdQJOPStF5Pcaww7jXjOqnunWuWwPTS936f_i7JXxud84eHUu_WX-_6LlB7HzE3oR0xCQIBRV7HgOVvzVj5QELaXKPRxnjHy1rqIXe_Pylbxhsruvvld7AP9NZqPI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16886864</pqid></control><display><type>article</type><title>Antibiotic prophylaxis in peripheral vascular and orthopaedic prosthetic surgery</title><source>MEDLINE</source><source>Oxford University Press Journals Digital Archive Legacy</source><creator>STRACHAN, C</creator><creatorcontrib>STRACHAN, C</creatorcontrib><description>Peripheral vascular by-pass and orthopaedic joint replacement surgery have much in common. The consequences of infection are serious and occasionally fatal. The incidence of infection varies from 0·5% to 3% depending on the anatomical site; the infecting organisms and distribution of organisms are similar. In orthopaedics a clean theatre environment, high local concentrations of anti-biotic in the cement and systemic antibiotic prophylaxis are well established methods of reducing infection rates and are supported by clinical trials. In contrast, scientific evidence supporting these three tenets is lacking for peripheral vascular surgery. There are wide variations in the choice of prophylaxis cover for peripheral vascular surgery and the first clinical cases of antibiotic containing graft material have only recently been described. The choice of an ideal antibiotic for the prophylaxis of infections associated with vascular surgery is debatable; wound and graft infections in those receiving antibiotic prophylaxis range from 0·9% to 5·8% and 0·0 to 0·9%, respectively. For both forms of surgery whether single dose, short course or longer periods of prophylaxis is preferred, it is agreed that the antibiotic must achieve adequate concentrations at the time of potential bacterial contamination. One of the limiting factors of single dose prophylaxis is the ability of the antibiotic to penetrate bone, soft tissue or haematoma. However, single dose prophylactic antibiotic cover in prosthetic surgery will attract increasing support whenever the criteria of spectrum and ‘risk period’ cover is fulfilled. This may help to contain the increase in multi-resistant bacteria, particularly staphylococci within the hospital ecosystem. Prolonged systemic administration can now be replaced by high local antibacterial activity at the site of prosthesis insertion via a bonded sealant or an impregnated cement. This permits high activity which can last for several weeks until all the lines are removed and tissue incorporation has become established.</description><identifier>ISSN: 0305-7453</identifier><identifier>EISSN: 1460-2091</identifier><identifier>DOI: 10.1093/jac/31.suppl_B.65</identifier><identifier>PMID: 8449847</identifier><identifier>CODEN: JACHDX</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Anti-Bacterial Agents - administration &amp; dosage ; Anti-Bacterial Agents - therapeutic use ; Bacterial Infections - etiology ; Bacterial Infections - prevention &amp; control ; Biological and medical sciences ; Humans ; Medical sciences ; Miscellaneous ; Orthopedics - methods ; Peripheral Vascular Diseases - surgery ; Postoperative Complications - microbiology ; Postoperative Complications - prevention &amp; control ; Premedication ; Public health. Hygiene ; Public health. Hygiene-occupational medicine</subject><ispartof>Journal of antimicrobial chemotherapy, 1993, Vol.31 (suppl-B), p.65-78</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c423t-7a01417c42ba2ffdcba56d94de3384b26c619aaeffe4f015d52d64bfece09d2c3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>309,310,314,780,784,789,790,4024,4050,4051,23930,23931,25140,27923,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=6339146$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=6359321$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8449847$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>STRACHAN, C</creatorcontrib><title>Antibiotic prophylaxis in peripheral vascular and orthopaedic prosthetic surgery</title><title>Journal of antimicrobial chemotherapy</title><addtitle>J Antimicrob Chemother</addtitle><description>Peripheral vascular by-pass and orthopaedic joint replacement surgery have much in common. The consequences of infection are serious and occasionally fatal. The incidence of infection varies from 0·5% to 3% depending on the anatomical site; the infecting organisms and distribution of organisms are similar. In orthopaedics a clean theatre environment, high local concentrations of anti-biotic in the cement and systemic antibiotic prophylaxis are well established methods of reducing infection rates and are supported by clinical trials. In contrast, scientific evidence supporting these three tenets is lacking for peripheral vascular surgery. There are wide variations in the choice of prophylaxis cover for peripheral vascular surgery and the first clinical cases of antibiotic containing graft material have only recently been described. The choice of an ideal antibiotic for the prophylaxis of infections associated with vascular surgery is debatable; wound and graft infections in those receiving antibiotic prophylaxis range from 0·9% to 5·8% and 0·0 to 0·9%, respectively. For both forms of surgery whether single dose, short course or longer periods of prophylaxis is preferred, it is agreed that the antibiotic must achieve adequate concentrations at the time of potential bacterial contamination. One of the limiting factors of single dose prophylaxis is the ability of the antibiotic to penetrate bone, soft tissue or haematoma. However, single dose prophylactic antibiotic cover in prosthetic surgery will attract increasing support whenever the criteria of spectrum and ‘risk period’ cover is fulfilled. This may help to contain the increase in multi-resistant bacteria, particularly staphylococci within the hospital ecosystem. Prolonged systemic administration can now be replaced by high local antibacterial activity at the site of prosthesis insertion via a bonded sealant or an impregnated cement. This permits high activity which can last for several weeks until all the lines are removed and tissue incorporation has become established.</description><subject>Anti-Bacterial Agents - administration &amp; dosage</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Bacterial Infections - etiology</subject><subject>Bacterial Infections - prevention &amp; control</subject><subject>Biological and medical sciences</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Miscellaneous</subject><subject>Orthopedics - methods</subject><subject>Peripheral Vascular Diseases - surgery</subject><subject>Postoperative Complications - microbiology</subject><subject>Postoperative Complications - prevention &amp; control</subject><subject>Premedication</subject><subject>Public health. Hygiene</subject><subject>Public health. Hygiene-occupational medicine</subject><issn>0305-7453</issn><issn>1460-2091</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU9v1DAQxS1EVZaWD8ABKQfELVs7YzvxsVSURa0ESFRCXKyJ_7Au2SS1E9T99rhstNeeRtb7vaeZZ0LeMrpmVMHFPZoLYOs0j2OnP66leEFWjEtaVlSxl2RFgYqy5gJekdcp3VNKpZDNKTltOFcNr1fk22U_hTYMUzDFGIdxu-_wMaQi9MXoYhi3LmJX_MVk5g5jgb0thjhthxGdPVjStHVP7jTH3y7uz8mJxy65N8s8I3fXn35cbcrbr5-_XF3eloZXMJU1UsZZnR8tVt5b06KQVnHrABreVtJIphCd9457yoQVlZW89c44qmxl4Ix8OOTmFR5mlya9C8m4rsPeDXPStZAASopnQSabRjaSZ5AdQJOPStF5Pcaww7jXjOqnunWuWwPTS936f_i7JXxud84eHUu_WX-_6LlB7HzE3oR0xCQIBRV7HgOVvzVj5QELaXKPRxnjHy1rqIXe_Pylbxhsruvvld7AP9NZqPI</recordid><startdate>1993</startdate><enddate>1993</enddate><creator>STRACHAN, C</creator><general>Oxford University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>1993</creationdate><title>Antibiotic prophylaxis in peripheral vascular and orthopaedic prosthetic surgery</title><author>STRACHAN, C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c423t-7a01417c42ba2ffdcba56d94de3384b26c619aaeffe4f015d52d64bfece09d2c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Anti-Bacterial Agents - administration &amp; dosage</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Bacterial Infections - etiology</topic><topic>Bacterial Infections - prevention &amp; control</topic><topic>Biological and medical sciences</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Miscellaneous</topic><topic>Orthopedics - methods</topic><topic>Peripheral Vascular Diseases - surgery</topic><topic>Postoperative Complications - microbiology</topic><topic>Postoperative Complications - prevention &amp; control</topic><topic>Premedication</topic><topic>Public health. Hygiene</topic><topic>Public health. Hygiene-occupational medicine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>STRACHAN, C</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of antimicrobial chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>STRACHAN, C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antibiotic prophylaxis in peripheral vascular and orthopaedic prosthetic surgery</atitle><jtitle>Journal of antimicrobial chemotherapy</jtitle><addtitle>J Antimicrob Chemother</addtitle><date>1993</date><risdate>1993</risdate><volume>31</volume><issue>suppl-B</issue><spage>65</spage><epage>78</epage><pages>65-78</pages><issn>0305-7453</issn><eissn>1460-2091</eissn><coden>JACHDX</coden><abstract>Peripheral vascular by-pass and orthopaedic joint replacement surgery have much in common. The consequences of infection are serious and occasionally fatal. The incidence of infection varies from 0·5% to 3% depending on the anatomical site; the infecting organisms and distribution of organisms are similar. In orthopaedics a clean theatre environment, high local concentrations of anti-biotic in the cement and systemic antibiotic prophylaxis are well established methods of reducing infection rates and are supported by clinical trials. In contrast, scientific evidence supporting these three tenets is lacking for peripheral vascular surgery. There are wide variations in the choice of prophylaxis cover for peripheral vascular surgery and the first clinical cases of antibiotic containing graft material have only recently been described. The choice of an ideal antibiotic for the prophylaxis of infections associated with vascular surgery is debatable; wound and graft infections in those receiving antibiotic prophylaxis range from 0·9% to 5·8% and 0·0 to 0·9%, respectively. For both forms of surgery whether single dose, short course or longer periods of prophylaxis is preferred, it is agreed that the antibiotic must achieve adequate concentrations at the time of potential bacterial contamination. One of the limiting factors of single dose prophylaxis is the ability of the antibiotic to penetrate bone, soft tissue or haematoma. However, single dose prophylactic antibiotic cover in prosthetic surgery will attract increasing support whenever the criteria of spectrum and ‘risk period’ cover is fulfilled. This may help to contain the increase in multi-resistant bacteria, particularly staphylococci within the hospital ecosystem. Prolonged systemic administration can now be replaced by high local antibacterial activity at the site of prosthesis insertion via a bonded sealant or an impregnated cement. This permits high activity which can last for several weeks until all the lines are removed and tissue incorporation has become established.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>8449847</pmid><doi>10.1093/jac/31.suppl_B.65</doi><tpages>14</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0305-7453
ispartof Journal of antimicrobial chemotherapy, 1993, Vol.31 (suppl-B), p.65-78
issn 0305-7453
1460-2091
language eng
recordid cdi_proquest_miscellaneous_75633965
source MEDLINE; Oxford University Press Journals Digital Archive Legacy
subjects Anti-Bacterial Agents - administration & dosage
Anti-Bacterial Agents - therapeutic use
Bacterial Infections - etiology
Bacterial Infections - prevention & control
Biological and medical sciences
Humans
Medical sciences
Miscellaneous
Orthopedics - methods
Peripheral Vascular Diseases - surgery
Postoperative Complications - microbiology
Postoperative Complications - prevention & control
Premedication
Public health. Hygiene
Public health. Hygiene-occupational medicine
title Antibiotic prophylaxis in peripheral vascular and orthopaedic prosthetic surgery
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T18%3A59%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antibiotic%20prophylaxis%20in%20peripheral%20vascular%20and%20orthopaedic%20prosthetic%20surgery&rft.jtitle=Journal%20of%20antimicrobial%20chemotherapy&rft.au=STRACHAN,%20C&rft.date=1993&rft.volume=31&rft.issue=suppl-B&rft.spage=65&rft.epage=78&rft.pages=65-78&rft.issn=0305-7453&rft.eissn=1460-2091&rft.coden=JACHDX&rft_id=info:doi/10.1093/jac/31.suppl_B.65&rft_dat=%3Cproquest_cross%3E16886864%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16886864&rft_id=info:pmid/8449847&rfr_iscdi=true